SCHEMBL19081386

SCHEMBL19081386

CC1(C)c2ccccc2-c2c1cc1c(sc3cc4ccccc4cc31)c2-c1c2ccccc2c(-c2ccc3sc4ccccc4c3c2)c2ccccc12

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.30
POLB P06746 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081076 0.89 ESR1 (0.34)
SCHEMBL17945764 0.86 ALOX5 (0.34) ALOX5MAPT
SCHEMBL19082405 0.86 ALOX5 (0.33) ALOX5MAPTL3MBTL1
SCHEMBL19081084 0.84
SCHEMBL19081384 0.83 ALOX5 (0.34) ALOX5MAPT
SCHEMBL17944396 0.83 ALK (0.31)
SCHEMBL19080981 0.83
SCHEMBL19110286 0.82 ALDH1A1 (0.34) ALOX5MAPTALDH1A1POLBTDP1
SCHEMBL19110285 0.82 ALDH1A1 (0.34) ALOX5MAPTALDH1A1POLBTDP1
SCHEMBL17932245 0.81 ALOX5 (0.39) ALOX5MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885MAPT 1294/4885ALDH1A1 326/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885MAPT 1294/4885ALDH1A1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.